Page last updated: 2024-08-21

adamantane and Carcinoma, Epidermoid

adamantane has been researched along with Carcinoma, Epidermoid in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Burlaka, YB; Grin, NV; Khilchevskyi, OM; Sukhoveev, OV; Verevka, SV1
Chen, J; Yu, H; Zhou, J1
Lanzi, C; Supino, R; Zanchi, C; Zuco, V; Zunino, F1

Other Studies

3 other study(ies) available for adamantane and Carcinoma, Epidermoid

ArticleYear
EPR spectroscopy studies of changes in erythrocyte membranes in patients with laryngeal cancer.
    Experimental oncology, 2017, Volume: 39, Issue:1

    Topics: Adamantane; Aged; Carcinoma, Squamous Cell; Electron Spin Resonance Spectroscopy; Erythrocyte Membrane; Humans; Laryngeal Neoplasms; Lipid Bilayers; Male; Membrane Fluidity; Membrane Lipids; Membrane Proteins; Middle Aged; Molecular Probes; Molecular Structure; Neoplasm Staging; Piperidines; Time Factors; Viscosity

2017
Targeting sphingosine kinase 2 by ABC294640 inhibits human skin squamous cell carcinoma cell growth.
    Biochemical and biophysical research communications, 2018, 03-04, Volume: 497, Issue:2

    Topics: Adamantane; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Humans; Male; Mice, Nude; Molecular Targeted Therapy; Phosphotransferases (Alcohol Group Acceptor); Pyridines; Skin Neoplasms

2018
Modulation of survival signaling pathways and persistence of the genotoxic stress as a basis for the synergistic interaction between the atypical retinoid ST1926 and the epidermal growth factor receptor inhibitor ZD1839.
    Cancer research, 2005, Mar-15, Volume: 65, Issue:6

    Topics: Adamantane; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carcinoma, Squamous Cell; Caspase 8; Caspases; Cell Cycle; Cell Growth Processes; Cell Line, Tumor; Cinnamates; DNA Damage; Drug Synergism; Enzyme Activation; ErbB Receptors; Female; Gefitinib; Humans; Ovarian Neoplasms; Quinazolines; Receptors, TNF-Related Apoptosis-Inducing Ligand; Receptors, Tumor Necrosis Factor; Signal Transduction; Vulvar Neoplasms

2005